Dimensional Fund Advisors
VIGL

Dimensional Fund Advisors’s Vigil Neuroscience VIGL Stock Holding History

Dimensional Fund Advisors’s Portfolio VIGL Stock Details VIGL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-10,704
Closed -$19.1K – 3335
2025
Q1 		$19.1K Buy
+10,704
New +$24K ﹤0.01% 3307

Other funds holding VIGL

AVLSA
Atlas Venture Life Science Advisors Cambridge, Massachusetts $881M AUM 160.77% 1-Year Est. Return
BCM
Beryl Capital Management Redondo Beach, California $111M AUM 205.39% 1-Year Est. Return
GCL
Glazer Capital LLC New York $4.07B AUM 78.71% 1-Year Est. Return
OBAM
ODDO BHF Asset Management Paris, France $2.16B AUM 43.32% 1-Year Est. Return
6CM
683 Capital Management New York $2.04B AUM 94.26% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
GF
Gabelli Funds Rye, New York $15.7B AUM 36.4% 1-Year Est. Return
AAM
Alpine Associates Management Palm Beach, Florida $1.6B AUM 93.19% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $1.1B AUM 197.64% 1-Year Est. Return
HCM
Highbridge Capital Management New York $4.11B AUM 26.03% 1-Year Est. Return

Dimensional Fund Advisors's VIGL Position: Q2 2025 in Review

Dimensional Fund Advisors sold out of Vigil Neuroscience (VIGL) in Q2 2025, closing a stake of 10,704 shares — an estimated $19.1K sold.

Dimensional Fund Advisors first reported a position in VIGL in Q1 2025 and held it in 1 quarter. The position peaked at $19.1K in Q1 2025. 78 funds tracked by Wall St. Rank hold VIGL as of Q2 2025.

  • Dimensional Fund Advisors reported no remaining Vigil Neuroscience position as of Q2 2025 after selling out during the quarter.
  • Dimensional Fund Advisors sold 10,704 Vigil Neuroscience shares in Q2 2025, an estimated $19.1K.
  • Dimensional Fund Advisors first reported a position in Vigil Neuroscience in Q1 2025 and held it in 1 quarter.
  • Dimensional Fund Advisors's Vigil Neuroscience position peaked at $19.1K in Q1 2025.
  • 78 funds tracked by Wall St. Rank held Vigil Neuroscience as of Q2 2025.

Based on Dimensional Fund Advisors's 13F filing for Q2 2025, filed 12 Aug 2025.